{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:05:08Z","timestamp":1781575508292,"version":"3.54.5"},"publisher-location":"Berlin, Heidelberg","reference-count":165,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783662558782","type":"print"},{"value":"9783662558805","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/7854_2016_464","type":"book-chapter","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T21:46:46Z","timestamp":1494971206000},"page":"361-391","source":"Crossref","is-referenced-by-count":67,"title":["Therapeutic Applications of Classic Hallucinogens"],"prefix":"10.1007","author":[{"given":"Michael P.","family":"Bogenschutz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"464_CR1","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archpsyc.1983.01790070074009","volume":"40","author":"HD Abraham","year":"1983","unstructured":"Abraham HD (1983) Visual phenomenology of the LSD flashback. Arch Gen Psychiatry 40:884\u2013889","journal-title":"Arch Gen Psychiatry"},{"key":"464_CR2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000468273","volume":"6","author":"FS Abuzzahab","year":"1971","unstructured":"Abuzzahab FS, Anderson BJ (1971) A review of LSD treatment in alcoholism. Int Pharmacopsychiatry 6:223\u2013235","journal-title":"Int Pharmacopsychiatry"},{"key":"464_CR3","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1176\/ajp.131.11.1247","volume":"131","author":"BJ Albaugh","year":"1974","unstructured":"Albaugh BJ, Anderson PO (1974) Peyote in the treatment of alcoholism among American Indians. Am J Psychiatry 131:1247\u20131250","journal-title":"Am J Psychiatry"},{"key":"464_CR4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1017\/S0033291700029962","volume":"21","author":"P Allebeck","year":"1991","unstructured":"Allebeck P, Bolund C (1991) Suicides and suicide attempts in cancer patients. Psychol Med 21:979\u2013984","journal-title":"Psychol Med"},{"key":"464_CR6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugalcdep.2010.09.006","volume":"114","author":"MJ Baggott","year":"2011","unstructured":"Baggott MJ, Coyle JR, Erowid E, Erowid F, Robertson LC (2011) Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaire. Drug Alcohol Depend 114:61\u201367","journal-title":"Drug Alcohol Depend"},{"key":"464_CR7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.molmed.2006.10.005","volume":"12","author":"RD Baler","year":"2006","unstructured":"Baler RD, Volkow ND (2006) Drug addiction: the neurobiology of disrupted self-control. Trends Mol Med 12:559\u2013566","journal-title":"Trends Mol Med"},{"key":"464_CR8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/dta.1383","volume":"4","author":"PC Barbosa","year":"2012","unstructured":"Barbosa PC, Mizumoto S, Bogenschutz MP, Strassman RJ (2012) Health status of ayahuasca users. Drug Test Anal 4:601\u2013609","journal-title":"Drug Test Anal"},{"key":"464_CR9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/2045125314527985","volume":"4","author":"D Baumeister","year":"2014","unstructured":"Baumeister D, Barnes G, Giaroli G, Tracy D (2014) Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles. Ther Adv Psychopharmacol 4:156\u2013169","journal-title":"Ther Adv Psychopharmacol"},{"key":"464_CR10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF02896052","volume":"84","author":"K Beringer","year":"1923","unstructured":"Beringer K (1923) Experimentelle Psychosen durch Mescalin. Zeitschrift f\u00fcr die gesamte Neurologie und Psychiatrie 84:426\u2013433","journal-title":"Zeitschrift f\u00fcr die gesamte Neurologie und Psychiatrie"},{"key":"464_CR11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/dta.1376","volume":"4","author":"MP Bogenschutz","year":"2012","unstructured":"Bogenschutz MP, Pommy JM (2012) Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses. Drug Test Anal 4:543\u2013555","journal-title":"Drug Test Anal"},{"key":"464_CR12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pnpbp.2015.03.002","volume":"64","author":"MP Bogenschutz","year":"2016","unstructured":"Bogenschutz MP, Johnson MW (2016) Classic hallucinogens in the treatment of addictions. Prog Neuropsychopharmacol Biol Psychiatry 64:250\u2013258","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"464_CR13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","volume":"29","author":"Michael P Bogenschutz","year":"2015","unstructured":"Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa P, Strassman RJ (2015a). Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 29(3):289\u2013299","journal-title":"Journal of Psychopharmacology"},{"key":"464_CR14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","volume":"29","author":"MP Bogenschutz","year":"2015","unstructured":"Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ (2015b) Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 29:289\u2013299","journal-title":"J Psychopharmacol"},{"key":"464_CR15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00005053-197002000-00003","volume":"150","author":"WT Bowen","year":"1970","unstructured":"Bowen WT, Soskin RA, Chotlos JW (1970) Lysergic acid diethylamide as a variable in the hospital treatment of alcoholism: a follow-up study. J Nerv Ment Dis 150:111\u2013118","journal-title":"J Nerv Ment Dis"},{"key":"464_CR16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1099-1611(199909\/10)8:5<417::AID-PON398>3.0.CO;2-4","volume":"8","author":"MJ Brady","year":"1999","unstructured":"Brady MJ, Peterman AH, Fitchett G, Mo M, Cella D (1999) A case for including spirituality in quality of life measurement in oncology. Psychooncology 8:417\u2013428","journal-title":"Psychooncology"},{"key":"464_CR17","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1001\/jama.284.22.2907","volume":"284","author":"W Breitbart","year":"2000","unstructured":"Breitbart W, Rosenfeld B, Pessin H, Kaim M, Funesti-Esch J, Galietta M, Nelson CJ, Brescia R (2000) Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA 284:2907\u20132911","journal-title":"JAMA"},{"key":"464_CR18","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/01.PSY.0000077503.96903.A6","volume":"65","author":"KW Brown","year":"2003","unstructured":"Brown KW, Levy AR, Rosberger Z, Edgar L (2003) Psychological distress and cancer survival: a follow-up 10\u00a0years after diagnosis. Psychosom Med 65:636\u2013643","journal-title":"Psychosom Med"},{"key":"464_CR20","unstructured":"Buckman J (1967) Theoretical aspects of LSD therapy. In: Abramson HA (ed) The use of LSD in psychotherapy and alcoholism. Bobbs-Merrill, Indianapolis"},{"key":"464_CR21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1548-5315(11)70702-1","volume":"3","author":"BD Bultz","year":"2006","unstructured":"Bultz BD, Holland JC (2006) Emotional distress in patients with cancer: the sixth vital sign. Community Oncology 3:311\u2013314","journal-title":"Community Oncology"},{"key":"464_CR22","first-page":"241","volume":"11","author":"AK Busch","year":"1950","unstructured":"Busch AK, Johnson WC (1950) L.S.D. 25 as an aid in psychotherapy; preliminary report of a new drug. Dis Nerv Syst 11:241\u2013243","journal-title":"Dis Nerv Syst"},{"key":"464_CR23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jat\/20.6.492","volume":"20","author":"JC Callaway","year":"1996","unstructured":"Callaway JC, Raymon LP, Hearn WL, McKenna DJ, Grob CS, Brito GS, Mash DC (1996) Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca. J Anal Toxicol 20:492\u2013497","journal-title":"J Anal Toxicol"},{"key":"464_CR24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/14659890903271624","volume":"15","author":"RL Carhart-Harris","year":"2010","unstructured":"Carhart-Harris RL, Nutt DJ (2010) User perceptions of the benefits and harms of hallucinogenic drug use: a web-based questionnaire study. J Subst Use 15:283\u2013300","journal-title":"J Subst Use"},{"key":"464_CR25","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","volume":"109","author":"RL Carhart-Harris","year":"2012","unstructured":"Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R, Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ (2012a) Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci USA 109:2138\u20132143","journal-title":"Proc Natl Acad Sci USA"},{"key":"464_CR26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1192\/bjp.bp.111.103309","volume":"200","author":"RL Carhart-Harris","year":"2012","unstructured":"Carhart-Harris RL, Leech R, Williams TM, Erritzoe D, Abbasi N, Bargiotas T, Hobden P, Sharp DJ, Evans J, Feilding A, Wise RG, Nutt DJ (2012b) Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. Br J Psychiatry 200:238\u2013244","journal-title":"Br J Psychiatry"},{"key":"464_CR27","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/schbul\/sbs117","volume":"39","author":"RL Carhart-Harris","year":"2013","unstructured":"Carhart-Harris RL, Leech R, Erritzoe D, Williams TM, Stone JM, Evans J, Sharp DJ, Feilding A, Wise RG, Nutt DJ (2013) Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis. Schizophr Bull 39:1343\u20131351","journal-title":"Schizophr Bull"},{"issue":"4","key":"464_CR28","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00213-014-3714-z","volume":"232","author":"R. L. Carhart-Harris","year":"2014","unstructured":"Carhart-Harris RL, Kaelen M, Whalley MG, Bolstridge M, Feilding A, Nutt DJ (2014a) LSD enhances suggestibility in healthy volunteers. Psychopharmacology 232(4):785\u2013794 (Berl)","journal-title":"Psychopharmacology"},{"key":"464_CR29","first-page":"20","volume":"8","author":"RL Carhart-Harris","year":"2014","unstructured":"Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, Chialvo DR, Nutt D (2014b) The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Front Hum Neurosci 8:20","journal-title":"Front Hum Neurosci"},{"key":"464_CR30","doi-asserted-by":"crossref","unstructured":"Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ (2016) Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry","DOI":"10.1016\/S2215-0366(16)30065-7"},{"key":"464_CR31","volume-title":"Management of cancer symptoms: pain, depression, and fatigue","author":"D Carr","year":"2002","unstructured":"Carr D, Goudas L, Lawrence D et al (2002) Management of cancer symptoms: pain, depression, and fatigue. Agency for Healthcare Research and Quality, Rockville"},{"key":"464_CR32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1056\/NEJM198203183061104","volume":"306","author":"EJ Cassel","year":"1982","unstructured":"Cassel EJ (1982) The nature of suffering and the goals of medicine. N Engl J Med 306:639\u2013645","journal-title":"N Engl J Med"},{"key":"464_CR34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.15288\/qjsa.1959.20.577","volume":"20","author":"N Chwelos","year":"1959","unstructured":"Chwelos N, Blewett DB, Smith CM, Hoffer A (1959) Use of d-lysergic acid diethylamide in the treatment of alcoholism. Q J Stud Alcohol 20:577\u2013590","journal-title":"Q J Stud Alcohol"},{"key":"464_CR35","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1440-1614.2002.01086.x","volume":"36","author":"DM Clarke","year":"2002","unstructured":"Clarke DM, Kissane DW (2002) Demoralization: its phenomenology and importance. Aust N Z J Psychiatry 36:733\u2013742","journal-title":"Aust N Z J Psychiatry"},{"key":"464_CR36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00005053-196001000-00005","volume":"130","author":"S Cohen","year":"1960","unstructured":"Cohen S (1960) Lysergic acid diethylamide: side effects and complications. J Nerv Ment Dis 130:30\u201340","journal-title":"J Nerv Ment Dis"},{"key":"464_CR37","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0140-6736(55)91156-9","volume":"268","author":"HA Cooper","year":"1955","unstructured":"Cooper HA (1955) Hallucinogenic drugs. Lancet 268:1078\u20131079","journal-title":"Lancet"},{"key":"464_CR39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/02791072.2005.10399794","volume":"37","author":"E Doering-Silveira","year":"2005","unstructured":"Doering-Silveira E, Grob CS, de Rios MD, Lopez E, Alonso LK, Tacla C, da Silveira DX (2005) Report on psychoactive drug use among adolescents using ayahuasca within a religious context. J Psychoactive Drugs 37:141\u2013144","journal-title":"J Psychoactive Drugs"},{"key":"464_CR40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/shm\/hkl039","volume":"19","author":"E Dyck","year":"2006","unstructured":"Dyck E (2006) \u2018Hitting highs at rock bottom\u2019: LSD treatment for alcoholism, 1950\u20131970. Soc Hist Med 19:313\u2013329","journal-title":"Soc Hist Med"},{"key":"464_CR41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/SPC.0b013e3283530d13","volume":"6","author":"NM Nawawi El","year":"2012","unstructured":"El Nawawi NM, Balboni MJ, Balboni TA (2012) Palliative care and spiritual care: the crucial role of spiritual care in the care of patients with advanced illness. Curr Opin Support Palliat Care 6:269\u2013274","journal-title":"Curr Opin Support Palliat Care"},{"key":"464_CR42","first-page":"130","volume":"73","author":"H Ellis","year":"1898","unstructured":"Ellis H (1898) Mescal: a new artificial paradise. Contemp Rev 73:130\u2013141","journal-title":"Contemp Rev"},{"key":"464_CR43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jep.2005.04.022","volume":"101","author":"HR El-Seedi","year":"2005","unstructured":"El-Seedi HR, de Smet PA, Beck O, Possnert G, Bruhn JG (2005) Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas. J Ethnopharmacol 101:238\u2013242","journal-title":"J Ethnopharmacol"},{"key":"464_CR44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugalcdep.2010.03.024","volume":"111","author":"JM Fabregas","year":"2010","unstructured":"Fabregas JM, Gonzalez D, Fondevila S, Cutchet M, Fernandez X, Barbosa PC, Alcazar-Corcoles MA, Barbanoj MJ, Riba J, Bouso JC (2010) Assessment of addiction severity among ritual users of ayahuasca. Drug Alcohol Depend 111:257\u2013261","journal-title":"Drug Alcohol Depend"},{"key":"464_CR45","first-page":"887","volume":"25","author":"BR Ferrell","year":"1998","unstructured":"Ferrell BR, Grant MM, Funk BM, Otis-Green SA, Garcia NJ (1998) Quality of life in breast cancer survivors: implications for developing support services. Oncol Nurs Forum 25:887\u2013895","journal-title":"Oncol Nurs Forum"},{"key":"464_CR46","unstructured":"Frankl V (1984) Man\u2019s search for meaning. Simon & Schuster, New York"},{"key":"464_CR47","first-page":"189","volume":"8","author":"E Frecska","year":"2006","unstructured":"Frecska E, Luna LE (2006) The adverse effects of hallucinogens from intramural perspective. Neuropsychopharmacol Hung 8:189\u2013200","journal-title":"Neuropsychopharmacol Hung"},{"key":"464_CR49","first-page":"246","volume":"43","author":"V Gabermann","year":"1978","unstructured":"Gabermann V (1978) Estimation of mescaline and pellotine in Lophophora coulter plants (Cactaceae) by means of the oscillographic polarography. Biokhimiia 43:246\u2013251","journal-title":"Biokhimiia"},{"key":"464_CR50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1360-0443.2006.01652.x","volume":"102","author":"RS Gable","year":"2007","unstructured":"Gable RS (2007) Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction 102:24\u201334","journal-title":"Addiction"},{"key":"464_CR51","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/pon.613","volume":"11","author":"TL Gall","year":"2002","unstructured":"Gall TL, Cornblat MW (2002) Breast cancer survivors give voice: a qualitative analysis of spiritual factors in long-term adjustment. Psychooncology 11:524\u2013535","journal-title":"Psychooncology"},{"key":"464_CR52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1874473708666150107121331","volume":"7","author":"A Garcia-Romeu","year":"2014","unstructured":"Garcia-Romeu A, Griffiths RR, Johnson MW (2014) Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Curr Drug Abuse Rev 7:157\u2013164","journal-title":"Curr Drug Abuse Rev"},{"key":"464_CR53","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1525\/maq.2000.14.4.521","volume":"14","author":"JF Garrity","year":"2000","unstructured":"Garrity JF (2000) Jesus, peyote, and the holy people: alcohol abuse and the ethos of power in Navajo healing. Med Anthropol Q 14:521\u2013542","journal-title":"Med Anthropol Q"},{"issue":"7","key":"464_CR54","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","volume":"202","author":"Peter Gasser","year":"2014","unstructured":"Gasser P, Holstein D, Michel Y, Doblin R, Yazar-Klosinski B, Passie T, Brenneisen R (2014) Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis 202:513","journal-title":"The Journal of Nervous and Mental Disease"},{"key":"464_CR55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0269881114555249","volume":"29","author":"P Gasser","year":"2015","unstructured":"Gasser P, Kirchner K, Passie T (2015) LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects. J Psychopharmacol 29:57\u201368","journal-title":"J Psychopharmacol"},{"key":"464_CR56","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tips.2008.06.006","volume":"29","author":"MA Geyer","year":"2008","unstructured":"Geyer MA, Vollenweider FX (2008) Serotonin research: contributions to understanding psychoses. Trends Pharmacol Sci 29:445\u2013453","journal-title":"Trends Pharmacol Sci"},{"key":"464_CR58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0024-3205(98)00262-8","volume":"63","author":"S Giacomelli","year":"1998","unstructured":"Giacomelli S, Palmery M, Romanelli L, Cheng CY, Silvestrini B (1998) Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro. Life Sci 63:215\u2013222","journal-title":"Life Sci"},{"key":"464_CR59","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1176\/appi.psychotherapy.2000.54.4.486","volume":"54","author":"M Greenstein","year":"2000","unstructured":"Greenstein M, Breitbart W (2000) Cancer and the experience of meaning: a group psychotherapy program for people with cancer. Am J Psychother 54:486\u2013500","journal-title":"Am J Psychother"},{"issue":"3","key":"464_CR61","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","volume":"187","author":"R. R. Griffiths","year":"2006","unstructured":"Griffiths RR, Richards WA, Mccann U, Jesse R (2006) Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl) 187:268\u2013283 (discussion 284\u2013292)","journal-title":"Psychopharmacology"},{"key":"464_CR62","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0269881108094300","volume":"22","author":"R Griffiths","year":"2008","unstructured":"Griffiths R, Richards W, Johnson M, McCann U, Jesse R (2008) Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14\u00a0months later. J Psychopharmacol 22:621\u2013632","journal-title":"J Psychopharmacol"},{"issue":"12","key":"464_CR002","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"Roland R Griffiths","year":"2016","unstructured":"Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol 30:1181\u20131197","journal-title":"Journal of Psychopharmacology"},{"key":"464_CR64","volume-title":"Psychedelic drugs reconsidered","author":"L Grinspoon","year":"1997","unstructured":"Grinspoon L, Balakar JB (1997) Psychedelic drugs reconsidered. The Lindesmith Center, New York"},{"key":"464_CR65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","volume":"68","author":"CS Grob","year":"2011","unstructured":"Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR (2011) Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry 68:71\u201378","journal-title":"Arch Gen Psychiatry"},{"key":"464_CR66","volume-title":"LSD psychotherapy","author":"S Grof","year":"2008","unstructured":"Grof S (2008) LSD psychotherapy. Multidisciplinary Association for Psychedlic Studies, Ben Lomond"},{"key":"464_CR67","volume-title":"The human encounter with death","author":"S Grof","year":"1977","unstructured":"Grof S, Halifax J (1977) The human encounter with death. EP Dutton, New York"},{"key":"464_CR68","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000467984","volume":"8","author":"S Grof","year":"1973","unstructured":"Grof S, Goodman LE, Richards WA, Kurland AA (1973a) LSD-assisted psychotherapy in patients with terminal cancer. Int Pharmacopsychiatry 8:129\u2013144","journal-title":"Int Pharmacopsychiatry"},{"key":"464_CR69","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000467979","volume":"8","author":"S Grof","year":"1973","unstructured":"Grof S, Soskin RA, Richards WA, Kurland AA (1973b) DPT as an adjunct in psychotherapy of alcoholics. Int Pharmacopsychiatry 8:104\u2013115","journal-title":"Int Pharmacopsychiatry"},{"key":"464_CR70","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1017\/S1461145713000722","volume":"16","author":"AL Halberstadt","year":"2013","unstructured":"Halberstadt AL, Geyer MA (2013) Serotonergic hallucinogens as translational models relevant to schizophrenia. Int J Neuropsychopharmacol 16:2165\u20132180","journal-title":"Int J Neuropsychopharmacol"},{"key":"464_CR71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/16066359609010756","volume":"4","author":"JH Halpern","year":"1996","unstructured":"Halpern JH (1996) The use of hallucinogens in the treatment of addiction. Addict Res 4:177\u2013189","journal-title":"Addict Res"},{"key":"464_CR72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0376-8716(02)00306-X","volume":"69","author":"JH Halpern","year":"2003","unstructured":"Halpern JH, Pope HG (2003) Hallucinogen persisting perception disorder: what do we know after 50\u00a0years? Drug Alcohol Depend 69:109\u2013119","journal-title":"Drug Alcohol Depend"},{"key":"464_CR73","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.biopsych.2005.06.038","volume":"58","author":"JH Halpern","year":"2005","unstructured":"Halpern JH, Sherwood AR, Hudson JI, Yurgelun-Todd D, Pope HG (2005) Psychological and cognitive effects of long-term peyote use among Native Americans. Biol Psychiatry 58:624\u2013631","journal-title":"Biol Psychiatry"},{"key":"464_CR74","unstructured":"Halpern JH, Sherwood AR, Passie T, Blackwell KC, Ruttenber AJ (2008) Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament. Med Sci Monit 14:SR15\u2013SR22"},{"key":"464_CR75","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","volume":"172","author":"F Hasler","year":"2004","unstructured":"Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX (2004) Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. Psychopharmacology 172:145\u2013156","journal-title":"Psychopharmacology"},{"key":"464_CR76","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cber.18960290145","volume":"29","author":"A Heffter","year":"1896","unstructured":"Heffter A (1896) Ueber Cacteenalkalo\u00efde. Ber Dtsch Chem Ges 29:216\u2013227","journal-title":"Ber Dtsch Chem Ges"},{"key":"464_CR77","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF01825267","volume":"40","author":"A Heffter","year":"1898","unstructured":"Heffter A (1898) Ueber Pellote - Beitr\u00e4ge zur chemischen und pharmakologischen Kenntniss der Cacteen Zweite Mittheilung. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology 40:385\u2013429","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"464_CR78","unstructured":"Hoffer A (1967) A program for treatment of alcoholism: LSD, malvaria, and nicotinic acid. In: Abramson HA (ed) The use of LSD in psychotherapy and alcoholism. Bobbs-Merrill, Indianapolis"},{"key":"464_CR79","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/02791072.1979.10472092","volume":"11","author":"A Hofmann","year":"1979","unstructured":"Hofmann A (1979) How LSD originated. J Psychedelic Drugs 11:53\u201360","journal-title":"J Psychedelic Drugs"},{"key":"464_CR80","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF02160424","volume":"14","author":"A Hofmann","year":"1958","unstructured":"Hofmann A, Frey A, Ott H, Petrzilka T, Troxler F (1958a) Konstitutionsaufkl\u04d3rung und Synthese von Psilocybin. Experientia 14:397\u2013401","journal-title":"Experientia"},{"key":"464_CR81","first-page":"17","volume":"22","author":"A Hofmann","year":"1958","unstructured":"Hofmann A, Heim R, Brack A, Kobel H (1958b) Psilocybin ein psychotroper Wirkstoff aus dem mexikanischen Rauschpilz. Rev Mycologie 22:17\u201321","journal-title":"Rev Mycologie"},{"key":"464_CR82","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1176\/ajp.125.10.1352","volume":"125","author":"LE Hollister","year":"1969","unstructured":"Hollister LE, Shelton J, Krieger G (1969) A controlled comparison of lysergic acid diethylamide (LSD) and dextroamphetmine in alcoholics. Am J Psychiatry 125:1352\u20131357","journal-title":"Am J Psychiatry"},{"key":"464_CR83","unstructured":"Institute of Medicine (2008) Cancer care for the whole patient: meeting psychosocial health needs. The National Academies Press, Washington, DC"},{"key":"464_CR84","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00408109","volume":"1","author":"H Isbell","year":"1959","unstructured":"Isbell H (1959) Comparison of the reactions induced by psilocybin and LSD-25 in man. Psychopharmacologia 1:29\u201338","journal-title":"Psychopharmacologia"},{"key":"464_CR85","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/09540261.2013.868788","volume":"26","author":"R Jaiswal","year":"2014","unstructured":"Jaiswal R, Alici Y, Breitbart W (2014) A comprehensive review of palliative care in patients with cancer. Int Rev Psychiatry 26:87\u2013101","journal-title":"Int Rev Psychiatry"},{"key":"464_CR88","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","volume":"22","author":"M Johnson","year":"2008","unstructured":"Johnson M, Richards W, Griffiths R (2008) Human hallucinogen research: guidelines for safety. J Psychopharmacol 22:603\u2013620","journal-title":"J Psychopharmacol"},{"key":"464_CR89","doi-asserted-by":"crossref","unstructured":"Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR (2014) Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol 0269881114548296","DOI":"10.1177\/0269881114548296"},{"key":"464_CR91","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.neubiorev.2006.03.004","volume":"30","author":"A Karl","year":"2006","unstructured":"Karl A, Schaefer M, Malta LS, Dorfel D, Rohleder N, Werner A (2006) A meta-analysis of structural brain abnormalities in PTSD. Neurosci Biobehav Rev 30:1004\u20131031","journal-title":"Neurosci Biobehav Rev"},{"key":"464_CR92","first-page":"80","volume":"26","author":"E Kast","year":"1966","unstructured":"Kast E (1966) LSD and the dying patient. Chic Med Sch Q 26:80\u201387","journal-title":"Chic Med Sch Q"},{"key":"464_CR93","first-page":"285","volume":"43","author":"EC Kast","year":"1964","unstructured":"Kast EC, Collins VJ (1964) Study of lysergic acid diethylamide as an analgesic agent. Anesth Analg 43:285\u2013291","journal-title":"Anesth Analg"},{"key":"464_CR94","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0006-3223(03)00273-7","volume":"54","author":"WJ Katon","year":"2003","unstructured":"Katon WJ (2003) Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 54:216\u2013226","journal-title":"Biol Psychiatry"},{"key":"464_CR95","first-page":"1022","volume":"29","author":"DW Kissane","year":"2000","unstructured":"Kissane DW (2000) Psychospiritual and existential distress. The challenge for palliative care. Aust Fam Physician 29:1022\u20131025","journal-title":"Aust Fam Physician"},{"key":"464_CR96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pon.1493","volume":"18","author":"D Kissane","year":"2009","unstructured":"Kissane D (2009) Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psychooncology 18:1\u20135","journal-title":"Psychooncology"},{"issue":"8","key":"464_CR97","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","volume":"78","author":"Rainer Kraehenmann","year":"2015","unstructured":"Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX (2014). Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers. Biol Psychiatry 78(8):572\u2013581","journal-title":"Biological Psychiatry"},{"issue":"7","key":"464_CR98","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0269881112439253","volume":"26","author":"Teri S Krebs","year":"2012","unstructured":"Krebs TS, Johansen PO (2012) Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials. J Psychopharmacol 26(7):994\u20131002","journal-title":"Journal of Psychopharmacology"},{"key":"464_CR99","doi-asserted-by":"crossref","first-page":"e63972","DOI":"10.1371\/journal.pone.0063972","volume":"8","author":"TS Krebs","year":"2013","unstructured":"Krebs TS, Johansen PO (2013) Psychedelics and mental health: a population study. PLoS ONE 8:e63972","journal-title":"PLoS ONE"},{"key":"464_CR100","volume-title":"Drinking careers: a twenty-five year study of three Navajo populations","author":"SJ Kunitz","year":"1994","unstructured":"Kunitz SJ, Levy JE (1994) Drinking careers: a twenty-five year study of three Navajo populations. Yale University Press, New Haven"},{"key":"464_CR101","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugpo.2010.09.002","volume":"22","author":"BC Labate","year":"2011","unstructured":"Labate BC, Cavnar C (2011) The expansion of the field of research on ayahuasca: Some reflections about the ayahuasca track at the 2010 MAPS \u201cPsychedelic Science in the 21st Century\u201d conference. Int J Drug Policy 22:174\u2013178","journal-title":"Int J Drug Policy"},{"key":"464_CR102","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00005053-196312000-00007","volume":"137","author":"T Leary","year":"1963","unstructured":"Leary T, Litwin GH, Metzner R (1963) Reactions to psilocybin administered in a supportive environment. J Nerv Ment Dis 137:561\u2013573","journal-title":"J Nerv Ment Dis"},{"key":"464_CR103","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cpr.2007.07.013","volume":"28","author":"K Lemay","year":"2008","unstructured":"Lemay K, Wilson KG (2008) Treatment of existential distress in life threatening illness: a review of manualized interventions. Clin Psychol Rev 28:472\u2013493","journal-title":"Clin Psychol Rev"},{"key":"464_CR104","first-page":"92","volume":"39","author":"AG Lerner","year":"2002","unstructured":"Lerner AG, Gelkopf M, Skladman I, Oyffe I, Finkel B, Sigal M, Weizman A (2002) Flashback and hallucinogen persisting perception disorder: clinical aspects and pharmacological treatment approach. Isr J Psychiatry Relat Sci 39:92\u201399","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"464_CR105","unstructured":"Leuner H (1967) Present state of psycholytic therapy and its possibilities. In: Abramson HA (ed) The use of LSD in psychotherapy and alcoholism. Bobbs-Merrill, Indianapolis"},{"key":"464_CR106","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000226893","volume":"48","author":"F Levi","year":"1991","unstructured":"Levi F, Bulliard JL, la Vecchia C (1991) Suicide risk among incident cases of cancer in the Swiss Canton of Vaud. Oncology 48:44\u201347","journal-title":"Oncology"},{"key":"464_CR107","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1200\/JCO.2011.39.7372","volume":"30","author":"M Li","year":"2012","unstructured":"Li M, Fitzgerald P, Rodin G (2012) Evidence-based treatment of depression in patients with cancer. J Clin Oncol 30:1187\u20131196","journal-title":"J Clin Oncol"},{"key":"464_CR108","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/02791072.2012.704590","volume":"44","author":"MB Liester","year":"2012","unstructured":"Liester MB, Prickett JI (2012) Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions. J Psychoactive Drugs 44:200\u2013208","journal-title":"J Psychoactive Drugs"},{"key":"464_CR109","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.euroneuro.2014.05.008","volume":"24","author":"RP Litjens","year":"2014","unstructured":"Litjens RP, Brunt TM, Alderliefste GJ, Westerink RH (2014) Hallucinogen persisting perception disorder and the serotonergic system: a comprehensive review including new MDMA-related clinical cases. Eur Neuropsychopharmacol 24:1309\u20131323","journal-title":"Eur Neuropsychopharmacol"},{"key":"464_CR110","first-page":"11","volume":"35","author":"L Lu","year":"2009","unstructured":"Lu L, Liu Y, Zhu W, Shi J, Liu Y, Ling W, Kosten T (2009) Traditional medicine in the treatment of drug addiction. Am J Drug Alcohol Abuse 35:11","journal-title":"Am J Drug Alcohol Abuse"},{"key":"464_CR111","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1176\/appi.psychotherapy.1965.19.3.417","volume":"19","author":"AM Ludwig","year":"1965","unstructured":"Ludwig AM, Levine J (1965) A controlled comparison of five brief treatment techniques employing lsd, hypnosis, and psychotherapy. Am J Psychother 19:417\u2013435","journal-title":"Am J Psychother"},{"key":"464_CR112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/ajp.126.1.59","volume":"126","author":"A Ludwig","year":"1969","unstructured":"Ludwig A, Levine J, Stark L, Lazar R (1969) A clinical study of LSD treatment in alcoholism. Am J Psychiatry 126:59\u201369","journal-title":"Am J Psychiatry"},{"key":"464_CR113","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1177\/0269881111420188","volume":"25","author":"KA Maclean","year":"2011","unstructured":"Maclean KA, Johnson MW, Griffiths RR (2011) Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. J Psychopharmacol 25:1453\u20131461","journal-title":"J Psychopharmacol"},{"key":"464_CR114","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.118.543.229","volume":"118","author":"N Malleson","year":"1971","unstructured":"Malleson N (1971) Acute adverse reactions to LSD in clinical and experimental use in the United Kingdom. Br J Psychiatry 118:229\u2013230","journal-title":"Br J Psychiatry"},{"key":"464_CR115","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/02791072.1998.10399714","volume":"30","author":"M Mangini","year":"1998","unstructured":"Mangini M (1998) Treatment of alcoholism using psychedelic drugs: a review of the program of research. J Psychoactive Drugs 30:381\u2013418","journal-title":"J Psychoactive Drugs"},{"key":"464_CR116","volume-title":"The varieties of psychedelic experience: the classic guide to the effects of LSD on the human psyche","author":"R Masters","year":"2000","unstructured":"Masters R, Houston J (2000) The varieties of psychedelic experience: the classic guide to the effects of LSD on the human psyche. Park Street Press, Rochester"},{"key":"464_CR117","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(03)13310-7","volume":"361","author":"CS McClain","year":"2003","unstructured":"McClain CS, Rosenfeld B, Breitbart W (2003) Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients. Lancet 361:1603\u20131607","journal-title":"Lancet"},{"key":"464_CR118","unstructured":"Mckenna DJ (2007) The healing vine: Ayahuasca as medicine in the 21st century. In: Winkelman MJ, Roberts TB (eds) Psychedelic medicine: New evidence for hallucinogenic substances as treatments, vol 1. Praeger Publishers\/Greenwood Publishing Group, Westport"},{"key":"464_CR119","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0378-8741(84)90003-5","volume":"10","author":"DJ McKenna","year":"1984","unstructured":"McKenna DJ, Towers GH, Abbott F (1984) Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca. J Ethnopharmacol 10:195\u2013223","journal-title":"J Ethnopharmacol"},{"key":"464_CR120","volume-title":"Peyote Hunt","author":"B Meyerhoff","year":"1974","unstructured":"Meyerhoff B (1974) Peyote Hunt. Cornell, Ithaca"},{"key":"464_CR121","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","volume":"12","author":"AJ Mitchell","year":"2011","unstructured":"Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12:160\u2013174","journal-title":"Lancet Oncol"},{"key":"464_CR122","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","volume":"67","author":"FA Moreno","year":"2006","unstructured":"Moreno FA, Wiegand CB, Taitano EK, Delgado PL (2006) Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. J Clin Psychiatry 67:1735\u20131740","journal-title":"J Clin Psychiatry"},{"key":"464_CR123","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S1478951503030086","volume":"1","author":"H Murata","year":"2003","unstructured":"Murata H (2003) Spiritual pain and its care in patients with terminal cancer: construction of a conceptual framework by philosophical approach. Palliat Support Care 1:15\u201321","journal-title":"Palliat Support Care"},{"key":"464_CR124","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ajmg.b.32177","volume":"162B","author":"RM Murray","year":"2013","unstructured":"Murray RM, Paparelli A, Morrison PD, Marconi A, di Forti M (2013) What can we learn about schizophrenia from studying the human model, drug-induced psychosis? Am J Med Genet B Neuropsychiatr Genet 162B:661\u2013670","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"464_CR125","unstructured":"National Institute on Drug Abuse (2014) Hallucinogens\u2014LSD, peyote, psilocybin, and PCP [Online]. Accessed 12 Jan 2015"},{"key":"464_CR126","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1176\/appi.psy.43.3.213","volume":"43","author":"CJ Nelson","year":"2002","unstructured":"Nelson CJ, Rosenfeld B, Breitbart W, Galietta M (2002) Spirituality, religion, and depression in the terminally ill. Psychosomatics 43:213\u2013220","journal-title":"Psychosomatics"},{"key":"464_CR127","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","volume":"101","author":"DE Nichols","year":"2004","unstructured":"Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131\u2013181","journal-title":"Pharmacol Ther"},{"key":"464_CR128","unstructured":"O\u2019brien CP (2001) Drug addiction and drug abuse. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (eds) Goodman and Gilman\u2019s the Pharmacological Basis of Therapeutics. McGraw-Hill, New York"},{"key":"464_CR129","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jep.2010.07.021","volume":"131","author":"O Ogunbodede","year":"2010","unstructured":"Ogunbodede O, McCombs D, Trout K, Daley P, Terry M (2010) New mescaline concentrations from 14 taxa\/cultivars of Echinopsis spp. (Cactaceae) (\u201cSan Pedro\u201d) and their relevance to shamanic practice. J Ethnopharmacol 131:356\u2013362","journal-title":"J Ethnopharmacol"},{"key":"464_CR130","first-page":"149","volume":"5","author":"WN Pahnke","year":"1969","unstructured":"Pahnke WN (1969) Psychedelic drugs and mystical experience. Int Psychiatry Clin 5:149\u2013162","journal-title":"Int Psychiatry Clin"},{"key":"464_CR131","first-page":"144","volume":"9","author":"WN Pahnke","year":"1969","unstructured":"Pahnke WN, Kurland AA, Goodman LE, Richards WA (1969) LSD-assisted psychotherapy with terminal cancer patients. Curr Psychiatr Ther 9:144\u2013152","journal-title":"Curr Psychiatr Ther"},{"key":"464_CR132","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1001\/jama.1970.03170240060010","volume":"212","author":"WN Pahnke","year":"1970","unstructured":"Pahnke WN, Kurland AA, Unger S, Savage C, Grof S (1970) The experimental use of psychedelic (LSD) psychotherapy. JAMA 212:1856\u20131863","journal-title":"JAMA"},{"key":"464_CR133","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.2003.07.071","volume":"21","author":"AH Partridge","year":"2003","unstructured":"Partridge AH, Wang PS, Winer EP, Avorn J (2003) Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 21:602\u2013606","journal-title":"J Clin Oncol"},{"key":"464_CR134","unstructured":"Passie T (2005). A history of the use of psilocybin in psychotherapy. In: Metzner R (ed) Sacred Mushrooms of Visions: Teonanacatl. Park Street Press, Rochester"},{"key":"464_CR135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/1355621021000005937","volume":"7","author":"T Passie","year":"2002","unstructured":"Passie T, Seifert J, Schneider U, Emrich HM (2002) The pharmacology of psilocybin. Addict Biol 7:357\u2013364","journal-title":"Addict Biol"},{"issue":"Suppl 3","key":"464_CR137","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/annonc\/mds088","volume":"23","author":"CM Puchalski","year":"2012","unstructured":"Puchalski CM (2012) Spirituality in the cancer trajectory. Ann Oncol 23(Suppl 3):49\u201355","journal-title":"Ann Oncol"},{"key":"464_CR138","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/02791072.1977.10472060","volume":"9","author":"JC Rhead","year":"1977","unstructured":"Rhead JC, Soskin RA, Turek I, Richards WA, Yensen R, Kurland AA, Ota YO (1977) Psychedelic drug (DPT)-assisted psychotherapy with alcoholics: a controlled study. J Psychedelic Drugs 9:287\u2013300","journal-title":"J Psychedelic Drugs"},{"key":"464_CR139","volume-title":"SEER cancer statistics review, 1975\u20132005","year":"2007","unstructured":"Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse S, Lewis DR, Clegg L, Eisner MP, Reichman M, Edwards BK (eds) (2007) SEER cancer statistics review, 1975\u20132005. National Cancer Institute, Bethesda"},{"key":"464_CR140","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1176\/ajp.108.8.572","volume":"108","author":"M Rinkel","year":"1952","unstructured":"Rinkel M, Deshon HJ, Hyde RW, Solomon HC (1952) Experimental schizophrenia-like symptoms. Am J Psychiatry 108:572\u2013578","journal-title":"Am J Psychiatry"},{"key":"464_CR142","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/WNF.0b013e318261e193","volume":"35","author":"S Ross","year":"2012","unstructured":"Ross S, Peselow E (2012) Co-occurring psychotic and addictive disorders: neurobiology and diagnosis. Clin Neuropharmacol 35:235\u2013243","journal-title":"Clin Neuropharmacol"},{"issue":"12","key":"464_CR001","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"Stephen Ross","year":"2016","unstructured":"Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 30:1165\u20131180","journal-title":"Journal of Psychopharmacology"},{"key":"464_CR143","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1176\/ajp.130.3.329-b","volume":"130","author":"C Roy","year":"1973","unstructured":"Roy C (1973) Indian peyotists and alcohol. Am J Psychiatry 130:329\u2013330","journal-title":"Am J Psychiatry"},{"key":"464_CR144","first-page":"81","volume":"20","author":"Z Rydzy\u0144ski","year":"1978","unstructured":"Rydzy\u0144ski Z, Gruszczy\u0144ski W (1978) Treatment of alcoholism with psychotomimetic drugs. A follow-up study. Act Nerv Super (Praha) 20:81\u201382","journal-title":"Act Nerv Super (Praha)"},{"key":"464_CR145","first-page":"273","volume":"10","author":"Z Rydzy\u0144ski","year":"1968","unstructured":"Rydzy\u0144ski Z, Cwyna RS, Grzelak L, Jagiello W (1968) Prelminary report on the experience with psychosomimetic drugs in the treatment of alcobolism. Act Nerv Super (Praha) 10:273","journal-title":"Act Nerv Super (Praha)"},{"key":"464_CR146","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/082585978800400306","volume":"4","author":"C Saunders","year":"1988","unstructured":"Saunders C (1988) Spiritual pain. J Palliat Care 4:29\u201332","journal-title":"J Palliat Care"},{"key":"464_CR147","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archpsyc.1973.01750360040005","volume":"28","author":"C Savage","year":"1973","unstructured":"Savage C, McCabe OL (1973) Residential psychedelic (LSD) therapy for the narcotic addict. A controlled study. Arch Gen Psychiatry 28:808\u2013814","journal-title":"Arch Gen Psychiatry"},{"key":"464_CR149","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1570159X12666140619204251","volume":"12","author":"G Serafini","year":"2014","unstructured":"Serafini G, Howland RH, Rovedi F, Girardi P, Amore M (2014) The role of ketamine in treatment-resistant depression: a systematic review. Curr Neuropharmacol 12:444\u2013461","journal-title":"Curr Neuropharmacol"},{"key":"464_CR151","first-page":"69","volume":"4","author":"JN Sherwood","year":"1962","unstructured":"Sherwood JN, Stolaroff MJ, Harman WW (1962) The psychedelic experience\u2014a new concept in psychotherapy. J Neuropsychiatr 4:69\u201380","journal-title":"J Neuropsychiatr"},{"key":"464_CR152","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10\u201329","journal-title":"CA Cancer J Clin"},{"key":"464_CR154","first-page":"1214","volume":"97","author":"RG Smart","year":"1967","unstructured":"Smart RG, Bateman K (1967) Unfavourable reactions to LSD: a review and analysis of the available case reports. Can Med Assoc J 97:1214\u20131221","journal-title":"Can Med Assoc J"},{"key":"464_CR155","doi-asserted-by":"crossref","first-page":"469","DOI":"10.15288\/qjsa.1966.27.469","volume":"27","author":"RG Smart","year":"1966","unstructured":"Smart RG, Storm T, Baker EF, Solursh L (1966) A controlled study of lysergide in the treatment of alcoholism. 1. The effects on drinking behavior. Q J Stud Alcohol 27:469\u2013482","journal-title":"Q J Stud Alcohol"},{"key":"464_CR156","doi-asserted-by":"crossref","first-page":"406","DOI":"10.15288\/qjsa.1958.19.406","volume":"19","author":"CM Smith","year":"1958","unstructured":"Smith CM (1958) A new adjunct to the treatment of alcoholism: the hallucinogenic drugs. Q J Stud Alcohol 19:406\u2013417","journal-title":"Q J Stud Alcohol"},{"key":"464_CR157","doi-asserted-by":"crossref","first-page":"292","DOI":"10.15288\/qjsa.1959.20.292","volume":"20","author":"CM Smith","year":"1959","unstructured":"Smith CM (1959) Some reflections on the possible therapeutic effects of the hallucinogens; with special reference to alcoholism. Q J Stud Alcohol 20:292\u2013301","journal-title":"Q J Stud Alcohol"},{"key":"464_CR159","volume-title":"The peyote religion: a history","author":"O Stewart","year":"1987","unstructured":"Stewart O (1987) The peyote religion: a history. University of Oklahoma Press, Norman"},{"key":"464_CR160","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/1097-0142(19920315)69:6<1509::AID-CNCR2820690632>3.0.CO;2-J","volume":"69","author":"HH Storm","year":"1992","unstructured":"Storm HH, Christensen N, Jensen OM (1992) Suicides among Danish patients with cancer: 1971 to 1986. Cancer 69:1507\u20131512","journal-title":"Cancer"},{"key":"464_CR161","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00005053-198410000-00001","volume":"172","author":"RJ Strassman","year":"1984","unstructured":"Strassman RJ (1984) Adverse reactions to psychedelic drugs. A review of the literature. J Nerv Ment Dis 172:577\u2013595","journal-title":"J Nerv Ment Dis"},{"key":"464_CR162","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archpsyc.1994.03950020009001","volume":"51","author":"RJ Strassman","year":"1994","unstructured":"Strassman RJ, Qualls CR (1994) Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects. Arch Gen Psychiatry 51:85\u201397","journal-title":"Arch Gen Psychiatry"},{"key":"464_CR163","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1177\/0269881110382466","volume":"25","author":"E Studerus","year":"2011","unstructured":"Studerus E, Kometer M, Hasler F, Vollenweider FX (2011) Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. J Psychopharmacol 25:1434\u20131452","journal-title":"J Psychopharmacol"},{"key":"464_CR164","volume-title":"Results from the 2012 national survey on drug use and health: summary of national findings","author":"Substance Abuse and Mental Health Services Administration","year":"2013","unstructured":"Substance Abuse and Mental Health Services Administration (2013) Results from the 2012 national survey on drug use and health: summary of national findings. Substance Abuse and Mental Health Services Administration, Rockville"},{"key":"464_CR165","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF02157378","volume":"12","author":"S Szara","year":"1956","unstructured":"Szara S (1956) Dimethyltryptamine: its metabolism in man: the relation of its psychotic effect to serotonin metabolism. Experientia 12:441\u2013442","journal-title":"Experientia"},{"key":"464_CR166","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1002\/hbm.22562","volume":"35","author":"E Tagliazucchi","year":"2014","unstructured":"Tagliazucchi E, Carhart-Harris R, Leech R, Nutt D, Chialvo DR (2014) Enhanced repertoire of brain dynamical states during the psychedelic experience. Hum Brain Mapp 35:5442\u20135456","journal-title":"Hum Brain Mapp"},{"key":"464_CR167","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00002820-200308000-00002","volume":"26","author":"EJ Taylor","year":"2003","unstructured":"Taylor EJ (2003) Spiritual needs of patients with cancer and family caregivers. Cancer Nurs 26:260\u2013266","journal-title":"Cancer Nurs"},{"key":"464_CR168","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/15733998113099990003","volume":"6","author":"G Thomas","year":"2013","unstructured":"Thomas G, Lucas P, Capler NR, Tupper KW, Martin G (2013) Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada. Curr Drug Abuse Rev 6:30\u201342","journal-title":"Curr Drug Abuse Rev"},{"key":"464_CR169","doi-asserted-by":"crossref","first-page":"932","DOI":"10.15288\/qjsa.1970.31.932","volume":"31","author":"M Tomsovic","year":"1970","unstructured":"Tomsovic M, Edwards RV (1970) Lysergide treatment of schizophrenic and nonschizophrenic alcoholics: a controlled evaluation. Q J Stud Alcohol 31:932\u2013949","journal-title":"Q J Stud Alcohol"},{"key":"464_CR170","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1200\/JCO.2011.39.5632","volume":"30","author":"L Traeger","year":"2012","unstructured":"Traeger L, Greer JA, Fernandez-Robles C, Temel JS, Pirl WF (2012) Evidence-based treatment of anxiety in patients with cancer. J Clin Oncol 30:1197\u20131205","journal-title":"J Clin Oncol"},{"key":"464_CR173","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","volume":"11","author":"FX Vollenweider","year":"2010","unstructured":"Vollenweider FX, Kometer M (2010) The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci 11:642\u2013651","journal-title":"Nat Rev Neurosci"},{"key":"464_CR174","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","volume":"9","author":"FX Vollenweider","year":"1998","unstructured":"Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Babler A, Vogel H, Hell D (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. NeuroReport 9:3897\u20133902","journal-title":"NeuroReport"},{"key":"464_CR175","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0893-133X(98)00108-0","volume":"20","author":"FX Vollenweider","year":"1999","unstructured":"Vollenweider FX, Vontobel P, Hell D, Leenders KL (1999) 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man\u2014a PET study with [11C] raclopride. Neuropsychopharmacology 20:424\u2013433","journal-title":"Neuropsychopharmacology"},{"key":"464_CR176","unstructured":"Wasson RG (1957) Seeking the magic mushroom. Life Mag 42:100"},{"key":"464_CR177","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF02245940","volume":"118","author":"VJ Watts","year":"1995","unstructured":"Watts VJ, Lawler CP, Fox DR, Neve KA, Nichols DE, Mailman RB (1995) LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors. Psychopharmacology 118:401\u2013409","journal-title":"Psychopharmacology"},{"key":"464_CR179","unstructured":"Wilkins JN, Danovitch I, Gorelick DA (2014) Management of stimulant, hallucinogen, marijuana, phencyclidine, and club drug intoxication and withdrawal. In: Ries RA, Fiellin DA, Miller SA, Saitz R (eds) ASAM principles of addiction medicine, 5th edn. Wolters Kluwer"},{"key":"464_CR180","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1089\/jpm.2010.0536","volume":"14","author":"WD Winkelman","year":"2011","unstructured":"Winkelman WD, Lauderdale K, Balboni MJ, Phelps AC, Peteet JR, Block SD, Kachnic LA, Vanderweele TJ, Balboni TA (2011) The relationship of spiritual concerns to the quality of life of advanced cancer patients: preliminary findings. J Palliat Med 14:1022\u20131028","journal-title":"J Palliat Med"},{"issue":"3","key":"464_CR181","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00412109","volume":"3","author":"A. B. Wolbach","year":"1962","unstructured":"Wolbach AB Jr, Miner EJ, Isbell H (1962) Comparison of psilocin with psilocybin, mescaline and LSD-25. Psychopharmacologia 3:219\u2013223","journal-title":"Psychopharmacologia"},{"key":"464_CR183","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.bjc.6602424","volume":"92","author":"U Yousaf","year":"2005","unstructured":"Yousaf U, Christensen ML, Engholm G, Storm HH (2005) Suicides among Danish cancer patients 1971\u20131999. Br J Cancer 92:995\u20131000","journal-title":"Br J Cancer"},{"key":"464_CR184","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/1099-1611(200101\/02)10:1<19::AID-PON501>3.0.CO;2-6","volume":"10","author":"J Zabora","year":"2001","unstructured":"Zabora J, Brintzenhofeszoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psychooncology 10:19\u201328","journal-title":"Psychooncology"}],"container-title":["Current Topics in Behavioral Neurosciences","Behavioral Neurobiology of Psychedelic Drugs"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2016_464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T18:39:13Z","timestamp":1602095953000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/7854_2016_464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783662558782","9783662558805"],"references-count":165,"URL":"https:\/\/doi.org\/10.1007\/7854_2016_464","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}